HIV
Conference Coverage
Daily statin cuts cardiovascular risk in HIV
“These are types of people who, if they came to the doctor’s office right now before REPRIEVE, they would largely be told your risk score is not...
Feature
The evolving pulmonary landscape in HIV
“Should management be tailored for people with HIV infection?”
Latest News
Dried blood spot test validated for HIV, hep B, and hep C
“This method is particularly useful in high-risk settings such as homeless shelters, drug rehabilitation centers, and prisons, where ... it can be...
News
Perinatal HIV nearly eradicated in U.S.
Just 32 children in the country were diagnosed in 2019, compared with twice as many in 2010.
News from the FDA/CDC
HIV testing still suboptimal
“If we just look at the need for HIV testing based on who is at risk, I think that we are always going to fall short.”
Conference Coverage
Long-acting ART effective without viral suppression
“Instead of having the burden of taking a pill every day, patients with HIV can now have these choices of being able to forget about their...
Latest News
Doxy PEP does not lower risk of STIs in cisgender women
Women are known to be at higher risk of infection because the lining of the vagina is thinner than the skin of the penis, allowing for easier...
From the Journals
Scientists create ‘vagina on a chip’: What to know
Researchers see the chip as a way to facilitate vaginal health research and open the door to vital new treatments.
Feature
Highly anticipated HIV vaccine fails in large trial
The vaccine had been in development since 2019 and was given to 3,900 study participants through October 2022.
Latest News
Kaposi’s sarcoma: Antiretroviral-related improvements in survival measured
From 2004 to 2018, patients with HIV had lower 1- and 2-year overall survival rates than those of the uninfected.
News
FDA approves first-in-class drug for HIV
FDA has approved the medication lenacapavir (Sunlenca) for adults living with multidrug resistant HIV-1 infection.